Impact of the Interval Between Neoadjuvant Immunotherapy and Surgery on Prognosis in Esophageal Squamous Cell Carcinoma (ESCC): a Real-World Study.
Cancer Immunology Immunotherapy（2024）
关键词
Esophageal squamous cell carcinoma,Immunotherapy,Interval,Pathological complete response,Prognosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要